GlobeNewswire

Disc Medicine Announces Proposed $350 Million Public Offering of Common Stock and Pre-Funded Warrants
19/10/2026
WATERTOWN, Mass., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments [...]
Acumen Pharmaceuticals to Report Third Quarter Financial Results on October 26, 2026
19/10/2026
NEWTON, Mass., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/10/2026
SOUTH SAN FRANCISCO, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on October 15, 2026 it granted stock options to purchase an aggregate of 60,465 shares of [...]
Marriott Foundation invests $4 million in Children’s National mental healthcare
19/10/2026
The gift from The J. Willard and Alise S. Marriot Foundation increases access to mental healthcare through Children’s National primary care locations and Pediatric Health Network practices, ensuring more families [...]
Jemperli (dostarlimab) Approved in the U.S. as First and Only Immunotherapy for Adults with MSI-H/dMMR Locally Advanced Rectal Cancer
19/10/2026
Approval based on AZUR-1 data showing significant proportion of participants with no detectable signs of cancer one year or more after treatment No disease recurrences reported among responders after median follow up of [...]
Kane to Showcase revyve® at Wounds Canada National Hybrid Conference
19/10/2026
Engaging Canadian wound-care professionals, presenting data and discussing biofilm management in clinical practice WINNIPEG, Manitoba, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “ [...]
Maxim Hair Restoration, a Leading FUE Hair Transplant Provider, Named a 2026 Best of America Small Business Awards Winner
19/10/2026
BASA Awards® recognizes Maxim in the Health Care & Medical Center category New York City, NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Maxim Hair Restoration has been named among the winners of the 2026 Best of [...]
Xealth to Lead Session on AI Applications and Digital Technologies Reshaping Healthcare at IHF World Congress
19/10/2026
SEOUL, South Korea, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Xealth , the leader in digital health orchestration and deployment, today announced that Xealth CEO Mike McSherry will chair a session on innovative applications of [...]
Une thérapie révolutionnaire pour l’insuffisance cardiaque avancée : Repairon renforce son équipe de direction avec la nomination de Detlef Schumann, Ph.D., au poste de directeur des opérations
19/10/2026
Ce dirigeant du secteur biotechnologique apporte une expérience internationale en matière de direction et d’opérations, visant à accélérer le développement clinique, à étendre les activités et à mettre en œuvre des [...]
Groundbreaking therapy for advanced heart failure: Repairon Strengthens Executive Leadership with Appointment of Detlef Schumann, Ph.D. as Chief Operating Officer
19/10/2026
Biotech executive brings global leadership and operations experience to speed clinical development, expand operations, and carry out strategic growth plans. GÖTTINGEN, Germany and PROVIDENCE, R.I., Oct. 19, 2026 (GLOBE [...]
Baylor Genetics to Highlight Clinical and Diagnostic Utility of Genome Sequencing at the 2026 American Society of Human Genetics Annual Meeting
19/10/2026
HOUSTON, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics , a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced it will share new [...]
Leads Biolabs' Opamtistomig and LBL-034 Featured in Six Abstracts at 2026 ESMO Congress
19/10/2026
Three Studies Selected for Oral Presentation, Including a Late-Breaking Abstract; Data Highlight Durable Responses and Long-Term Survival Signals Across Immunologically Cold Tumors and Deep, Sustained Responses in [...]
FOXO TECHNOLOGIES INC.’S SUBSIDIARY, MYRTLE RECOVERY CENTERS, INC., ANNOUNCES EXPANSION OF ITS FLAGSHIP FACILITY AND FOCUS ON SUBSTANCE USE DISORDER PATIENTS WITH RELATED MEDICAL CARE NEEDS
19/10/2026
WEST PALM BEACH, FL, Oct. 19, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc.’s (OTC: FOXO) (“FOXO”) is pleased to announce that its subsidiary, Myrtle Recovery Centers, Inc. (“Myrtle”), recently received its license [...]
Phase 3 trial in China successfully confirms ACARIZAX® safety and efficacy in patients with house dust mite allergy
19/10/2026
Inside Information Phase 3 trial with ACARIZAX ® in Chinese participants met the primary objective and showed efficacy in line with previous trials, after only 24-28 weeks of treatment. ACARIZAX ® was shown to be safe [...]
Standard Dental Labs Signs $10 Million Equity Purchase Agreement with Twenty Four Capital
19/10/2026
Facility gives the Company discretion to access equity capital over time to support its Florida dental laboratory strategy ORLANDO, Fla., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (OTCQB: TUTH) (“SDL” [...]
BioCardia Announces FDA Acceptance of De Novo Pre-Submission Package for Helix™ Catheter Marketing Clearance FDA Substantive Review and Meeting Expected this Quarter
19/10/2026
SUNNYVALE, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA] , a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced [...]
PacBio and Verily Health Announce Multi-Year Strategic Collaboration to Scale Long-Read Genomics for Biomedical AI
19/10/2026
Verily Pre will connect PacBio HiFi Sequencing with governed cloud analysis, multimodal health data and AI-ready research workflows MENLO PARK, Calif. and DALLAS, Oct. 19, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB [...]
23andMe Research Institute to Showcase Scientific Impact and Expanded Research Capabilities at ASHG 2026
19/10/2026
New research and capabilities highlight the power of more than 11 million consented research participants PALO ALTO, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- At the American Society of Human Genetics (ASHG) 2026 Annual [...]
XBiotech Announces Positive Phase II Final Efficacy Results from Investigator-Sponsored TASKIN Trial in Refractory Metastatic Colorectal Cancer
19/10/2026
Investigator-sponsored study funded by the French National Cancer Institute (INCa) meets pre-specified primary efficacy success criterion with 61.3% 12-month overall survival. Exploratory Subgroup analysis reveals [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum